About The Journal
  Aims and Scope
  Editorial Board
  Submit a Manuscript 
  Subscription Information
  Guidelines for Publication
  Ethics
Articles & Issues
  Search
  Issue
  Online First
  KJChE on
For Authors
  Instructions to Authors
  Ethical Responsibilities of
  Authors in KJChE
  Ethics in Publishing
  Peer Review Process
  Author's Checklist
  Copyright Transfer Form
Contact us
 
 
 
Issue
Korean Journal of Chemical Engineering,
Vol.34, No.5, 1435-1443, 2017
Solubility of celecoxib in N-methyl-2-pyrrolidone+water mixtures at various temperatures: Experimental data and thermodynamic analysis
Nozohouri S, Shayanfar A, Cardenas ZJ, Martinez F, Jouyban A
Solubility is one of the most significant physicochemical properties of drugs, and improving the solubility of drugs is still a challenging subject in pharmaceutical sciences due to requirements of enhancing their bioavailability. Celecoxib, according to the biopharmaceutics classification system (BCS), is a class 2 drug, possessing low water solubility (<5 μg·mL-1) and high permeability. Increasing the solubility of this group can lead to improved bioavailability, dose reduction and subsequently, increased efficiency and reduced side effects. In this study, celecoxib solubility was determined in binary mixtures of N-methyl-2-pyrrolidone (NMP)+water at 293.2, 298.2, 303.2, 308.2 and 313.2 K. The solubility of celecoxib is increased with the addition of NMP to the aqueous solutions and reaches a maximum value in neat NMP. In addition, increased temperature leads to enhanced solubility of celecoxib in a given solvent composition. The solubility data of celecoxib in NMP+water at different temperatures were correlated using different mathematical models including, the Jouyban-Acree model and a combination of the Jouyban-Acree and van’t Hoff models. Thermodynamic parameters, Gibbs energy, enthalpy and entropy of dissolution processes were performed based on Gibbs and van’t Hoff equations. Thermodynamic analysis allowed observing two main entropy or enthalpy-driven dissolution mechanisms, varying according to the composition of aqueous mixtures. Moreover, preferential solvation of celecoxib by water is observed in water-rich mixtures but preferential solvation by NMP was seen in mixtures with similar composition and also in NMP-rich mixtures.
Keywords: Celecoxib; Solubility Profiles; Solubility Mathematical Model; Enthalpy-entropy Compensation; Thermodynamic Parameters
[References]
  1. Savjani KT, Gajjar AK, Savjani JK, ISRN. Pharm., 2012, 195727, 2012
  2. Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJH, Pharmacol. Rev., 65, 315, 2013
  3. Yang W, Wu K, Hu Y, Zhang T, Guo Q, Yang S, Shi Y, Korean J. Chem. Eng., 32(6), 1158, 2015
  4. Huang Z, Yu C, Xue W, Lin F, Zeng Z, Korean J. Chem. Eng., 34(1), 206, 2017
  5. Yeh MK, Chang LC, Chiou AH, AAPS PharmSciTech., 10, 166, 2009
  6. Stephens D, Li LC, Pec E, Robinson D, Drug Dev. Ind. Pharm., 25, 961, 1999
  7. Watkinson R, Guy R, Hadgraft J, Lane M, Skin Pharmacol. Physiol., 22, 225, 2009
  8. Proniuk S, Liederer BM, Dixon SE, Rein JA, Kallen MA, Blanchard J, J. Pharm. Sci., 91, 101, 2002
  9. Bendas B, Schmalfuβ U, Neubert R, Int. J. Pharm., 116, 19, 1995
  10. Rager T, Hilfiker R, Cryst. Growth Des., 10, 3237, 2010
  11. Porra R, Thompson W. Kriedemann P, Biochim. Biophys. Acta, 975, 384, 1989
  12. Zhao H, Dong J, Lu J, Chen J, Li Y, Shan L, Lin Y, Fan W, Gu G, J. Agric. Food Chem., 54, 7277, 2006
  13. Jouyban A, Fakhree MAA, Shayanfar A, J. Pharm. Pharm. Sci., 13, 524, 2010
  14. Bartsch W, Sponer G, Dietmann K, Fuchs G, Arzneimitt. Forsch., 26, 1581, 1975
  15. Tarantino R, Bishop E, Chen FC, Iqbal K, Malick AW, J. Pharm. Sci., 83, 1213, 1994
  16. Sanghvi R, Narazaki R, Machatha SG, Yalkowsky SH, AAPS PharmSciTech., 9, 366, 2008
  17. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS, JAMA, 284, 1247, 2000
  18. Davies NM, McLachlan AJ, Day RO, Williams KM, Clin. Pharmacokinet., 38, 225, 2000
  19. Rathi P, Jouyban A, Khoubnasabjafari M, Kale M, J. Chem. Eng. Data, 60(7), 2128, 2015
  20. Jouyban A, J. Pharm. Pharm. Sci., 11, 32, 2008
  21. Acree WE, Thermochim. Acta, 198, 71, 1992
  22. Jouyban-Gharamaleki A, Acree WE, Int. J. Pharm., 167, 177, 1998
  23. Williams NA, Amidon GL, J. Pharm. Sci., 73, 14, 1984
  24. Barzegar-Jalali M, Jouyban-Gharamaleki A, Int. J. Pharm., 152, 247, 1997
  25. Jouyban-Gharamaleki A, Chem. Pharm. Bull., 46, 1058, 1998
  26. Jouyban A, Chan HK, Romero S, Khoubnasabjafari M, Bustamante P, Pharmazie, 59, 117, 2004
  27. Barzegar-Jalali M, Hanaee J, Int. J. Pharm., 109, 291, 1994
  28. Barzegar-Jalali M, Jouyban-Gharamaleki A, Int. J. Pharm., 140, 237, 1996
  29. Jouyban-Gharamaleki A, Valaee L, Barzegar-Jalali M, Clark B, Acree WE, Int. J. Pharm., 177, 93, 1999
  30. Jouyban A, J. Pharm. Pharm. Sci., 9, 262, 2006
  31. Jouyban A, Chew NYK, Chan HK, Sabour M, Acree WE, Chem. Pharm. Bull., 53, 634, 2005
  32. Jouyban A, Shayanfar A, Panahi-Azar V, Soleymani J, Yousefi BH, Acree WE, York P, J. Pharm. Sci., 100, 4368, 2011
  33. Jouyban-Gharamaleki A, Hanaee J, Int. J. Pharm., 154, 245, 1997
  34. Grant D, Mehdizadeh M, Chow AL, Fairbrother J, Int. J. Pharm., 18, 25, 1984
  35. Eghrary SH, Zarghami R, Martinez F, Jouyban A, J. Chem. Eng. Data, 57(5), 1544, 2012
  36. Jouyban A, Fakhree MAA, Acree WE, J. Chem. Eng. Data, 57(4), 1344, 2012
  37. Jouyban A, Fakhree MAA, In: Acree WE, Toxicity and Drug Testing, InTech Publisher, New York, 187 (2012).
  38. Higuchi T, Connors KA, Adv. Anal. Chem. Instr., 4, 117, 1965
  39. Shayanfar A, Acree WE, Jouyban A, J. Chem. Eng. Data, 54(10), 2964, 2009
  40. Soltanpour S, Jouyban A, J. Solution Chem., 40, 2032, 2011
  41. Soltanpour S, Jafari B, Barzegar-Jalali M, Jouyban A, J. Drug Deliv. Sci. Technol., 24, 111, 2014
  42. Soltanpour S, Acree WE, Jouyban A, AAPS. PharmSciTech., 10, 1153, 2009
  43. Jouyban A, Shayanfar A, Acree WE, Fluid Phase Equilib., 293(1), 47, 2010
  44. Barzegar-Jalali M, Mohammadzade M, Martinez F, Jouyban A, J. Mol. Liq., 220, 484, 2016
  45. Guo X, Cheng YW, Wang LJ, Li X, J. Chem. Eng. Data, 53(7), 1421, 2008
  46. Jouyban A, Romero S, Chan HK, Clark BJ, Bustamante P, Chem Pharm Bull, 50, 594, 2002
  47. Millard JW, Alvarez-Nunez F, Yalkowsky S, Int. J. Pharm., 245, 153, 2002
  48. Jouyban A, Handbook of Solubility Data for Pharmaceuticals, CRC Press, Boca Raton, Florida (2010).
  49. Rodriguez GA, Delgado DR, Martinez F, Jouyban A, Acree WE, Fluid Phase Equilib., 320, 49, 2012
  50. Vahdati S, Shayanfar A, Hanaee J, Martinez F, Acree WE, Jouyban A, Ind. Eng. Chem. Res., 52(47), 16630, 2013
  51. Perlovich GL, Kurkov SV, Kinchin AN, Bauer-Brandl A, Eur. J. Pharm. Biopharm., 57, 411, 2004
  52. Bustamante P, Romero S, Pena A, Escalera B, Reillo A, J. Pharm. Sci., 87, 1590, 1998
  53. Ruidiaz MA, Delgado DR, Martinez F, Marcus Y, Fluid Phase Equilib., 299(2), 259, 2010
  54. Sotomayor RG, Holguin AR, Romdhani A, Martinez F, Jouyban A, J. Solution Chem., 42, 358, 2013
  55. Marcus Y, J. Mol. Liq., 140, 61, 2008
  56. Marcus Y, Acta Chim. Slov., 56, 40, 2009
  57. Marcus Y, Solvent Mixtures: Properties and Selective Solvation, Marcel Dekker, New York, 180 (2002).
  58. Marcus Y, The Properties of Solvents, Wiley, Chichester, 145 (1998).
  59. Henni A, Hromek JJ, Tontiwachwuthikul P, Chakma A, J. Chem. Eng. Data, 49(2), 231, 2004
  60. Fedors RF, Polym. Eng. Sci., 14, 147, 1974
  61. Delgado DR, Pena MA, Martinez F, J. Solution Chem., 43, 360, 2014
  62. Delgado DR, Almanza OA, Martinez F, Pena MA, Jouyban A, Acree WE, J. Chem. Thermodyn., 97, 264, 2016
참고문헌정보(참고문헌, 인용문헌)는 화학공학소재연구정보센터에 의해 제공되고 있습니다.